Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
Enhabit stock surges on $1.1 billion acquisition deal
Stock Market Today: The Dow Jones index dropped Monday on higher Trump tariffs. Novo stock plunged on weight-loss drug trial results.
The Austrian Financial Market Authority has frozen new business at KuCoin EU months after granting the exchange a MiCA license, citing gaps in key AML and...
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
Psyence Biomedical stock gains on equity investment deal
A booming AI economy may be very bad for the broader economy, according to Citrini Research
The February jobs report, and not the Supreme Court ruling overturning a large part of President Donald Trump's tariffs on imported goods, will be key to w...
Tariffs need to become law or the federal budget will take a hit. Lawmakers have less than 150 days to decide.
Airline stocks are taking a hit as a major Northeast snowstorm is leading to thousands of flight cancellations.
Honeywell International on Monday received a 26% discount on its deal to acquire a business tied to the struggling chemicals industry.
Decent growth, benign inflation, a dovish Fed and a weaker dollar all favor equities but international and emerging stocks look set to build on the outperf...